Skip to main content
. Author manuscript; available in PMC: 2016 Nov 23.
Published in final edited form as: Ann Surg Oncol. 2016 May 2;23(9):2874–2882. doi: 10.1245/s10434-016-5241-0

TABLE 2.

Demographics of patients according to development of postoperative hematoma

Characteristic No hematoma Hematoma p
No. of patients 4492 22
Age (years) 54 ± 0.2 55 ± 4.2 0.44
Patient gender
  Female 99.5 % 0.5 % 0.61
  Male 99.4 % 0.6 %
Target organ
  Thyroid 2375 (99.2 %) 20 (0.8 %) <0.001
  Parathyroid 2117 (99.9 %) 2 (0.1 %)
Extent of operation
  Unilateral 2322 (99.9 %) 3 (0.1 %) 0.002
  Bilateral 2049 (99.1 %) 18 (0.9 %)
  Extensive 121 (99.2 %) 1 (0.8 %)
Reoperative neck 496 (99.4 %) 3 (0.6 %) 0.73
Antiplatelet use
  None 3367 (99.5 %) 16 (0.5 %) 0.045
  <325 mg aspirin 669 (99.9 %) 1 (0.1 %)
  ≥325 mg aspirin 369 (99.2 %) 3 (0.8 %)
  Clopidogrel 87 (97.8 %) 2 (2.2 %)
Anticoagulant use
  None 4331 (99.6 %) 16 (0.4 %) <0.001
  Oral 136 (97.8 %) 3 (2.2 %)
  Injectable 25 (89.3 %) 3 (10.7 %)
Use of either medication type
  None 3251 (99.7 %) 11 (0.3 %) 0.033
  One 1199 (99.2 %) 10 (0.8 %)
  Both 42 (97.7 %) 1 (2.3 %)

Data are expressed as mean ± SEM or as n (%)